Page 2 - David Persing News Today

WASHINGTON (AP) — Too many Americans are missing out on a cure for hepatitis C, and a study underway in a hard-hit corner of Kentucky is exploring a simple way to start changing that.

Too many Americans are missing out on a cure for hepatitis C, and a study underway in a hard-hit corner of Kentucky is exploring a simple way to start changing that.

Kentucky researchers use a finger-prick of blood and make an on-the-spot diagnosis to start treatment right away for diseases like HIV and Hepatitis C.

WASHINGTON (AP) -- Too many Americans are missing out on a cure for hepatitis C, and a study underway in a hard-hit corner of Kentucky is exploring a

SUNNYVALE, Calif., Dec. 8, 2022 /PRNewswire/ -- Currently circulating mutant strains of influenza highlight the need for multi-target diagnostic tests. Two recently identified mutations in the

FDA-cleared PCR test aids in the faster identification of three distinct conditions within an hour SUNNYVALE, Calif., Nov. 15, 2022 /PRNewswire/ -- Cepheid announced today that it has launched Xpert... | November 15, 2022

BioGX previously helped develop a monkeypox and orthopoxvirus assay on the GeneXpert that was validated on clinical samples in 2017.

/PRNewswire/ -- Cepheid today announced it has received the CE mark for Xpert® Xpress CoV-2 plus, a rapid molecular diagnostic test for qualitative detection...

New "plus" version of test adds a 3rd gene target to enhance detection of future SARS-CoV-2 variants SUNNYVALE, Calif., May 19, 2022 /PRNewswire/ -- Cepheid today announced it has received

/PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress...